Amicus Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FOLD and other ETFs, options, and stocks.

About FOLD

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio.

CEO

Bradley Lewis Campbell

CEOBradley Lewis Campbell

Employees

499

Employees499

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2002

Founded2002

Employees

499

Employees499

FOLD Key Statistics

Market cap

4.42B

Market cap4.42B

Price-Earnings ratio

-319.46

Price-Earnings ratio-319.46

Dividend yield

—

Dividend yield—

Average volume

12.90M

Average volume12.90M

High today

$14.32

High today$14.32

Low today

$14.28

Low today$14.28

Open price

$14.29

Open price$14.29

Volume

10.55M

Volume10.55M

52 Week high

$14.36

52 Week high$14.36

52 Week low

$5.51

52 Week low$5.51

Stock Snapshot

Amicus Therapeutics(FOLD) stock is priced at $14.32, giving the company a market capitalization of 4.42B. It carries a P/E multiple of -319.46.

As of 2026-01-11, Amicus Therapeutics(FOLD) stock has fluctuated between $14.28 and $14.32. The current price stands at $14.32, placing the stock +0.3% above today's low and 0.0% off the high.

The Amicus Therapeutics(FOLD)'s current trading volume is 10.55M, compared to an average daily volume of 12.9M.

During the past year, Amicus Therapeutics(FOLD) stock moved between $5.51 at its lowest and $14.36 at its peak.

Analyst ratings

86%

of 7 ratings

Buy

14.3%

Hold

85.7%

Sell

People also own

Based on the portfolios of people who own FOLD. This list is generated using Robinhood data, and it’s not a recommendation.